Stop Lab Cuts

Scheduled reimbursement cuts under the Protecting Access to Medicare Act (PAMA) could jeopardize access to many of the clinical laboratory tests that are used to diagnose, monitor, and manage common diseases for more than 65 million seniors.

But the threat doesn’t stop there. After three prior rounds of up to 10 percent cuts, planned payment reductions of up to an additional 15 percent in 2024 may result in a weakened clinical lab infrastructure, making it more difficult to deliver routine health care and respond to the next public health crisis. Strong clinical laboratories are foundational to the U.S. health care system.

The Solution Is Simple: Enact H.R. 2377 / S. 1000, the Saving Access to Laboratory Services Act (SALSA).
SALSA would simplify the data reporting process by providing the Centers for Medicare & Medicaid Services (CMS) with the authority to collect data from a statistical sampling of all major types of laboratories that provide services to seniors, including independent, hospital, and physician office laboratories. Targeted sampling, as designed by SALSA, is a straightforward solution to collecting complete representative private market data to achieve accurate and sustainable Medicare rates for laboratory services. In the long-term, sustainability for lab reimbursement will support strong clinical laboratory infrastructure to protect public health and innovation in tomorrow’s diagnostics while providing robust access to improve patient health.

Let's tell Congress to Stop Lab Cuts.